These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 14144487)

  • 21. [PRESENT STATE OF ANTINEOPLASTIC CHEMOTHERAPY FROM THE PHARMACOLOGIC POINT OF VIEW].
    NANETTI L; VALLINI R
    Minerva Med; 1963 Nov; 54():3353-5. PubMed ID: 14126380
    [No Abstract]   [Full Text] [Related]  

  • 22. HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
    TELLER MN; WOLFF R; WAGSHUL SF
    Cancer Res; 1964 Jan; 24():114-9. PubMed ID: 14106153
    [No Abstract]   [Full Text] [Related]  

  • 23. INFLUENCE OF PURINE AND PYRIMIDINE COMPOUNDS ON DNA-SYNTHESIS OF ASCITES-TUMOUR CELLS.
    LANGEN P
    Acta Unio Int Contra Cancrum; 1964; 20():1012-4. PubMed ID: 14274681
    [No Abstract]   [Full Text] [Related]  

  • 24. ACUTE EFFECTS OF CYTOTOXIC COMPOUNDS ON INCORPORATION OF PRECURSORS INTO DNA, RNA, AND PROTEIN OF HELA MONOLAYERS.
    YOUNG CW; HODAS S
    Biochem Pharmacol; 1965 Mar; 14():205-14. PubMed ID: 14314318
    [No Abstract]   [Full Text] [Related]  

  • 25. THE ADVERSE EFFECTS OF CANCER CHEMOTHERAPY.
    KONDO T
    Acta Unio Int Contra Cancrum; 1964; 20():194-8. PubMed ID: 14151882
    [No Abstract]   [Full Text] [Related]  

  • 26. ENHANCEMENT OF THIOINOSINATE SYNTHESIS IN THE EHRLICH ASCITES CARCINOMA BY PRIOR TREATMENT WITH 6-MERCAPTOPURINE OR AZASERINE.
    PATERSON AR
    Acta Unio Int Contra Cancrum; 1964; 20():1033-6. PubMed ID: 14274687
    [No Abstract]   [Full Text] [Related]  

  • 27. CLINICAL INVESTIGATIONS IN CANCER CHEMOTHERAPY.
    SULLIVAN RD; WATKINS E; ZUREK WZ
    Lahey Clin Found Bull; 1964; 13():113-20. PubMed ID: 14163652
    [No Abstract]   [Full Text] [Related]  

  • 28. EFFECTS OF GROWTH-INHIBITING CHEMICALS ON THE SAND-DOLLAR EMBRYO, ECHINARACHNIUS PARMA.
    KARNOFSKY DA; SIMMEL EB
    Prog Exp Tumor Res; 1963; 3():254-95. PubMed ID: 14148383
    [No Abstract]   [Full Text] [Related]  

  • 29. GLUTAMINE SYNTHETASE. 3. FACTORS CONTROLLING ITS ACTIVITY IN THE DEVELOPING RAT.
    WU C
    Arch Biochem Biophys; 1964 Jul; 106():394-401. PubMed ID: 14217186
    [No Abstract]   [Full Text] [Related]  

  • 30. IN VITRO CULTURE OF YOSHIDA SARCOMA CELLS: METHODS FOR DETERMINING ACQUIRED RESISTANCE TO DRUGS.
    SAKURAI Y
    Natl Cancer Inst Monogr; 1964 Dec; 16():207-39. PubMed ID: 14235655
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.
    Nelson JA; Carpenter JW; Rose LM; Adamson DJ
    Cancer Res; 1975 Oct; 35(10):2872-8. PubMed ID: 1157053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INFLUENCES OF ANTICANCER AGENTS ON THE METABOLISM OF DELTA-AMINOLEVULINIC ACID IN MORMAL AND TUMOR-BEARING MICE.
    HANO K; AKASHI A
    Gan; 1964 Feb; 55():25-40. PubMed ID: 14133995
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of azaserine and 6-mercaptopurine on the in vivo metabolism of ascites tumor cells.
    FERNANDES JF; LEPAGE GA; LINDNER A
    Cancer Res; 1956 Feb; 16(2):154-61. PubMed ID: 13293657
    [No Abstract]   [Full Text] [Related]  

  • 34. ASSOCIATION OF INCREASED DIHYDROFOLATE REDUCTASE LEVELS AND CHROMOSOME ALTERATION IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210.
    SCHRECKER AW; VENDITTI JM; GREENBERG NH; BIEDLER JL; ROBINSON DL; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():557-74. PubMed ID: 14059003
    [No Abstract]   [Full Text] [Related]  

  • 35. THE METABOLISM OF THIOGUANINE IN PURINE ANALOG-RESISTANT CELLS.
    BIEBER AL; SARTORELLI AC
    Cancer Res; 1964 Aug; 24():1210-5. PubMed ID: 14216153
    [No Abstract]   [Full Text] [Related]  

  • 36. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 37. SOME METABOLIC EFFECTS EXERTED BY AZASERINE AND PURINE ANALOGS IN VIVO.
    SARTORELLI AC; UPCHURCH HF; BIEBER AL; BOOTH BA
    Cancer Res; 1964 Aug; 24():1202-9. PubMed ID: 14216152
    [No Abstract]   [Full Text] [Related]  

  • 38. III. IMPROVEMENT OF CANCER CHEMOTHERAPY IN MAN.
    BURCHENAL JH
    Acta Unio Int Contra Cancrum; 1964; 20():48-51. PubMed ID: 14151968
    [No Abstract]   [Full Text] [Related]  

  • 39. EFFECT OF AZASERINE ON THE INCORPORATION OF 14-C-LABELED PURINES AND PYRIMIDINES INTO ACID-SOLUBLE AND NUCLEIC ACID FRACTIONS OF TRYPANOSOMA EQUIPERDUM.
    MOMPARLER RL; JAFFE JJ
    Biochem Pharmacol; 1965 Mar; 14():255-62. PubMed ID: 14314323
    [No Abstract]   [Full Text] [Related]  

  • 40. TERATOGENESIS: EFFECTS OF SUBSTITUTED PURINES AND THE INFLUENCE OF 4-HYDROXYPYRAZOLOPYRIMIDINE IN THE RAT.
    BRAGONIER JR; ROESKY N; CARVER MJ
    Proc Soc Exp Biol Med; 1964 Jul; 116():685-8. PubMed ID: 14194634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.